Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Small, C. J.
Right arrow Articles by Bloom, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Small, C. J.
Right arrow Articles by Bloom, S. R.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 50:248-254, 2001
© 2001 by the American Diabetes Association, Inc.

Effects of Chronic Central Nervous System Administration of Agouti-Related Protein in Pair-Fed Animals

Caroline J. Small, Min S. Kim, Sarah A. Stanley, John R.D. Mitchell, Kevin Murphy, David G.A. Morgan, Mohammad A. Ghatei, and Stephen R. Bloom

From the Department of Metabolic Medicine, Division of Investigative Sciences, Imperial College School of Medicine, Hammersmith Hospital, London, U.K.

Address correspondence and reprint requests to Dr. Stephen R. Bloom, Department of Metabolic Medicine, Division of Investigative Sciences, Imperial College School of Medicine, Hammersmith Hospital, Du Cane Road, London, W12 ONN, U.K. Email: s.bloom{at}ic.ac.uk .

The melanocortin receptor (MC3-R and MC4-R) antagonist, agouti-related protein (AGRP), is a potent stimulant of food intake. We examined the effect of chronic intracerebroventricular (ICV) AGRP treatment on energy metabolism and pituitary function in ad libitum fed rats and rats administered AGRP and then pair-fed to a saline control group. Chronic ICV AGRP (83-132) administration (1 nmol/day for 7 days) significantly increased food intake and body weight in ad libitum fed animals compared with saline-treated controls (body weight on day 7: 272 ± 6 [saline] vs. 319 ± 8 g [AGRP ad libitum fed]; P < 0.001). A significant increase in the epididymal fat pad weight, interscapular brown adipose tissue (BAT) weight, and plasma leptin was also observed in the ad libitum fed group. In the AGRP pair-fed group, a significant increase in the epididymal fat pad weight, BAT weight, and plasma leptin was again observed, suggesting that AGRP caused metabolic changes independent of increased food intake. BAT uncoupling protein 1 (UCP-1) content was significantly decreased compared with saline controls in both the AGRP ad libitum fed (21 ± 8% of saline control; P < 0.01) and AGRP pair-fed groups (24 ± 7% of saline control; P < 0.01). Plasma thyroid-stimulating hormone (TSH) was significantly suppressed compared with saline controls in both the AGRP ad libitum fed and AGRP pair-fed groups (3.5 ± 0.3 [saline] vs. 2.7 ± 0.4 [AGRP ad libitum fed] vs. 2.1 ± 0.2 ng/ml [AGRP pairfed]; P < 0.01). This study demonstrates that independent of its orexigenic effects, chronic AGRP treatment decreased BAT UCP-1, suppressed plasma TSH, and increased fat mass and plasma leptin, suggesting that it may play a role in energy expenditure.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
A. D. Strader, H. Shi, R. Ogawa, R. J. Seeley, and O. Reizes
The Effects of the Melanocortin Agonist (MT-II) on Subcutaneous and Visceral Adipose Tissue in Rodents
J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1153 - 1161.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J.-C. Peter, J. R. Nicholson, D. Heydet, A.-C. Lecourt, J. Hoebeke, and K. G. Hofbauer
Antibodies against the melanocortin-4 receptor act as inverse agonists in vitro and in vivo
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2151 - R2158.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
H. Shimizu, K. Inoue, and M. Mori
The leptin-dependent and -independent melanocortin signaling system: regulation of feeding and energy expenditure
J. Endocrinol., April 1, 2007; 193(1): 1 - 9.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. Voss-Andreae, J. G. Murphy, K. L. J. Ellacott, R. C. Stuart, E. A. Nillni, R. D. Cone, and W. Fan
Role of the Central Melanocortin Circuitry in Adaptive Thermogenesis of Brown Adipose Tissue
Endocrinology, April 1, 2007; 148(4): 1550 - 1560.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. A. Sebag and P. M. Hinkle
Regulation of Endogenous Melanocortin-4 Receptor Expression and Signaling by Glucocorticoids
Endocrinology, December 1, 2006; 147(12): 5948 - 5955.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
S. Stanley, K. Wynne, B. McGowan, and S. Bloom
Hormonal Regulation of Food Intake
Physiol Rev, October 1, 2005; 85(4): 1131 - 1158.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
K. Wynne, S. Stanley, B. McGowan, and S. Bloom
Appetite control
J. Endocrinol., February 1, 2005; 184(2): 291 - 318.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
L. S. Tallam, J. J. Kuo, A. A. da Silva, and J. E. Hall
Cardiovascular, Renal, and Metabolic Responses to Chronic Central Administration of Agouti-Related Peptide
Hypertension, December 1, 2004; 44(6): 853 - 858.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. R. Vulliemoz, E. Xiao, L. Xia-Zhang, M. Germond, J. Rivier, and M. Ferin
Decrease in Luteinizing Hormone Pulse Frequency during a Five-Hour Peripheral Ghrelin Infusion in the Ovariectomized Rhesus Monkey
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5718 - 5723.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Wolden-Hanson, B. T. Marck, and A. M. Matsumoto
Blunted hypothalamic neuropeptide gene expression in response to fasting, but preservation of feeding responses to AgRP in aging male Brown Norway rats
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R138 - R146.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
F Bai, T Rankinen, C Charbonneau, D D Belsham, D C Rao, C Bouchard, and G Argyropoulos
Functional dimorphism of two hAgRP promoter SNPs in linkage disequilibrium
J. Med. Genet., May 1, 2004; 41(5): 350 - 353.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
T. Yasuda, T. Masaki, T. Kakuma, and H. Yoshimatsu
Hypothalamic Melanocortin System Regulates Sympathetic Nerve Activity in Brown Adipose Tissue
Experimental Biology and Medicine, March 1, 2004; 229(3): 235 - 239.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
B. CANNON and J. NEDERGAARD
Brown Adipose Tissue: Function and Physiological Significance
Physiol Rev, January 1, 2004; 84(1): 277 - 359.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. M. Cerda-Reverter and R. E. Peter
Endogenous Melanocortin Antagonist in Fish: Structure, Brain Mapping, and Regulation by Fasting of the Goldfish Agouti-Related Protein Gene
Endocrinology, October 1, 2003; 144(10): 4552 - 4561.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. M. Haqq, D. D. Stadler, R. G. Rosenfeld, K. L. Pratt, D. S. Weigle, R. S. Frayo, S. H. LaFranchi, D. E. Cummings, and J. Q. Purnell
Circulating Ghrelin Levels Are Suppressed by Meals and Octreotide Therapy in Children with Prader-Willi Syndrome
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3573 - 3576.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Fekete, S. Sarkar, W. M. Rand, J. W. Harney, C. H. Emerson, A. C. Bianco, and R. M. Lechan
Agouti-Related Protein (AGRP) Has a Central Inhibitory Action on the Hypothalamic-Pituitary-Thyroid (HPT) Axis; Comparisons between the Effect of AGRP and Neuropeptide Y on Energy Homeostasis and the HPT Axis
Endocrinology, October 1, 2002; 143(10): 3846 - 3853.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. Argyropoulos, T. Rankinen, D. R. Neufeld, T. Rice, M. A. Province, A. S. Leon, J. S. Skinner, J. H. Wilmore, D. C. Rao, and C. Bouchard
A Polymorphism in the Human Agouti-Related Protein Is Associated with Late-Onset Obesity
J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4198 - 4202.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
Y. Tsuruta, H. Yoshimatsu, S. Hidaka, S. Kondou, K. Okamoto, and T. Sakata
Hyperleptinemia in Ay/a mice upregulates arcuate cocaine- and amphetamine-regulated transcript expression
Am J Physiol Endocrinol Metab, April 1, 2002; 282(4): E967 - E973.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K. Baran, E. Preston, D. Wilks, G. J. Cooney, E. W. Kraegen, and A. Sainsbury
Chronic Central Melanocortin-4 Receptor Antagonism and Central Neuropeptide-Y Infusion in Rats Produce Increased Adiposity by Divergent Pathways
Diabetes, January 1, 2002; 51(1): 152 - 158.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. M. Wren, C. J. Small, C. R. Abbott, W. S. Dhillo, L. J. Seal, M. A. Cohen, R. L. Batterham, S. Taheri, S. A. Stanley, M. A. Ghatei, et al.
Ghrelin Causes Hyperphagia and Obesity in Rats
Diabetes, November 1, 2001; 50(11): 2540 - 2547.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2001 by the American Diabetes Association.